Dr. Reddy’s Labs reported a 15% decline in Q2 net profit, despite a 17% rise in revenue driven by global generics. While analysts acknowledge the strong revenue momentum, opinions are divided on the stock’s future prospects, with ratings ranging from ‘Buy’ to ‘Sell’.
Geopolitical winds set to sweeten India’s apple harvest
India’s apple imports are facing disruption. Geopolitics are influencing prices this harvest season. Traders are avoiding Turkish apples due to political tensions. The Attari-Wagah border